ACT EU’s Workplan 2022-2026
by Giuliana Miglierini The implementation phase of the Accelerating Clinical Trials in the EU (ACT EU) initiative, launched…
Revision of the PIC/S GMP Guide: Annex 13 and Annex 16
by Giuliana Miglierini The entry into force of EU Regulation 536/2014 “Clinical trials”, at the end of January,…
ACT EU: the EU’s vision for the future of clinical trials
by Giuliana Miglierini Just few days before the entry into force of the new Clinical Trials Regulation and…
Steps towards the final approval of the IP action plan
By Giuliana Miglierini The end of 2021 may see the final approval of many pieces of the new…
Commission establishes portfolio of 10 most promising treatments for Covid-19
by Giuliana Miglierini The second phase in the development of new medicines to treat Covid-19 – a part…
A new role for EMA and a pilot project for the repurposing of medicines
by Giuliana Miglierini A draft agreement was reached at the end of October between the Council of the…